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ABSTRACT  A  monoclonal  antibody,  IV-IA8, generated  against  chicken  type  IV collagen  has 
been characterized  and shown to bind specifically to a conformational-dependent  site within 
a major,  triple  helical  domain  of the type IV molecule.  Immunohistochemical  localization  of 
the antigenic determinant with IV-IA8 revealed  that the basement membranes  of a variety of 
chick tissues were stained but that the basement membrane of the corneal epithelium showed 
little,  if  any,  staining.  Thus,  basement  membranes  may  differ  in  their  content  of  type  IV 
collagen, or in the way in which it is assembled. The specificity of the antibody was determined 
by inhibition ELISA using purified collagen  types I-V and three purified molecular domains of 
chick type IV collagen  ([F112F2, F3, and 7S) as inhibitors. Only unfractionated type IV collagen 
and  the  (F1)2F2 domain  bound  the  antibody.  Antibody  binding was destroyed  by thermal 
denaturation  of  the  collagen,  the  loss occurring  at  a  temperature  similar  to  that  at  which 
previous optical rotatory dispersion studies had shown melting of the triple helical structure of 
(F1)2F2. Such domain-specific  monoclonal  antibodies  should  prove  to  be  useful  probes  in 
studies  involving  immunological  dissection  of  the  type  IV collagen  molecule,  its assembly 
within basement  membranes,  and changes in its distribution during normal  development and 
in disease. 
Basement membranes, a class of extracellular matrices which 
separate epithelia from connective tissues and surround some 
types of cells  such as smooth and skeletal muscle, have been 
implicated  in  mediating  cell  and  tissue  interactions  during 
embryonic development,  tissue  repair,  and  regeneration  (for 
reviews,  see references  1 and 2).  Evaluation of the proposed 
roles for these structures requires specific and sensitive probes 
for identification, localization, and manipulation of their var- 
ious molecular components. One such probe is the monoclonal 
antibody (3-5), which can be selected not only for specificity 
to an individual molecular component, but for specificity to an 
individual domain within a molecule. 
Type IV collagen is a major component of many basement 
membranes.  Recent  work  on  the  mouse  EHS-sarcoma  (6), 
chicken  gizzard  (7),  human  placenta  (8),  and  bovine  lens 
capsule (9) have provided some general information about the 
structure of the molecule (reviewed in references  10 and  11). 
The native type  IV collagen molecule  is  composed of three 
chains (each ~ 180,000 mol wt) representing at least two differ- 
ent gene products. These are assembled so that each molecule 
contains one  or more triple-helical  regions  (collagenous do- 
mains)  and at least  two regions in which the chains  are not 
folded  into  the  triple-helical  conformation  (noncollagenous 
domains). A model has been proposed to explain how type IV 
molecules  may  be  arranged  as  supramolecular  aggregates 
within basement membranes (12,  13). Its salient features have 
been inferred from specific enzymatic digestions coupled with 
electron microscopic observations of rotary shadowed prepa- 
rations. The model proposes that four molecules are arranged 
so that a  specific collagenous domain at or near one end of 
each of them overlaps with the same domain of the other three. 
The overlap region (termed 7S in reference to its sedimentation 
coefficient when isolated) is stabilized by multiple interchain 
disulfide  bonds.  It is  highly resistant  to enzymatic digestion 
and has a very high melting temperature  (14),  both of which 
are substantiaUy decreased by disulfide reduction.  Extending 
from the 7S domain are long triple-helical domains which are 
probably interrupted repeatedly by noncollagenous sequences 
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IV collagen from a mouse tumor (13) suggest that each collag- 
enous chain terminates  distally in a  noncollagenous globular 
domain  (termed  NC-1)  which  may associate  with  the  same 
domain on other molecules to form an interlocking collagen 
lattice. 
From type IV collagen extracted from chicken gizzard and 
kidney by pepsinization,  Mayne and co-workers (7,  17) have 
isolated and identified  two other domains in addition to 7S. 
The generation of these domains results from the presence of 
an additional  pepsin-sensitive  site  that  appears  to be absent 
from  mammalian  type  IV  collagen.  One  of these  domains, 
termed F3, is largely triple-helical, contains interchain disulfide 
bonds, and may be close to 7S. The other, termed (F1)2F2,  is 
also largely triple-helical  but contains no interchain disulfide 
bonds. This latter  region constitutes >90% of type IV collagen 
preparations extracted from chicken gizzard by limited pepsin 
digestion. 
Many questions are still unanswered. Do all basement mem- 
branes  contain  the  same  type  IV collagen,  or does  type  IV 
constitute a class of separate gene products with tissue specific 
distributions?  Is  type  IV  collagen  universally  distributed  in 
basement membranes or do some of them lack this molecule? 
How are the molecules assembled? Do the different structural 
domains of type IV interact independently with other molec- 
ular components of basement membranes, such as the recently 
characterized basement membrane proteoglycans (18) and gly- 
coproteins (19, 20)? Do any of the domains of type IV serve as 
"informational  macromolecules"  capable  of influencing  cell 
and tissue behavior during development or tissue repair?. 
We think that many of these questions can be approached 
most directly through the use of monoclonal antibodies specific 
for the  different  regions  of type  IV  collagen.  In  this  initial 
study we describe  a  monoclonal antibody which  specifically 
binds  to  a  conformational-dependent  determinant  located 
within the (F1)2F2 domain of type IV collagen extracted from 
chick gizzard. In addition, we demonstrate by immunofluores- 
cence  histochemistry  that  most  basement  membranes  react 
strongly with the antibody, demonstrating the presence of the 
antigenic  determinant;  several  others,  however,  stained  very 
lightly, if at all. 
MATERIALS  AND  METHODS 
Preparation of Collagens 
Chick collagen types [II, IV, and V were obtained by limited pepsin extraction 
of adult chicken gizzard or kidney and separated by fractional salt precipitations 
as previously described (7, 21). Some preparations were further purified by ion- 
exchange chromatography on carboxymethyl-cellulose (CM-cellulose) or dieth- 
ylaminoethyl-cellulose (DEAE cellulose) columns run under nondenaturing con- 
ditions (7, 21). Type I collagen was an acid extract of lathyritic chick skin, and 
type  II  was  a  pepsin  extract  of adult  chicken  sterna  purified  as  previously 
described (5). The antigen consisted of type IV collagen that had been passed 
over CM-cellulose in native conditions (7). Characterization of the antigen was 
performed by SDS PAGE, agarose gel filtration (A-5m), and rotary shadowing. 
The preparation consisted of >90% (F 1  ~zF2 together with 7S domains from which 
one or more arms of average length 215 am were observed (17). 
Highly purified (F 1  )2F2 was isolated first by CM-cellulose chromatography in 
native conditions followed by molecular sieving at 4 ° C on a 1.5 ×  150-era column 
of Agarose A-15, equilibrated with 1 M  CaC12. F3 and 7S +  arms were isolated 
by agarose gel filtration and, in the case of F3, by CM-cellulose chromatography 
in denaturing conditions (7).  The relative abundance of these domains within 
each of these fractions was confirmed by rotary shadowing. 
Preparation and Isolation of Hybridomas 
Female SJL/J mice (Jackson Laboratories, Bar Harbor, ME) were immunized 
with type IV collagen isolated from gizzard. The first injection (200#g in complete 
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Freund's) was administered subcutaneously at several sites along the flank. Two 
booster shots (-200/ag in incomplete Freund's) were administered intraperito- 
neatly at 2-wk intervals. The mice were rested for 6 me. On the four consecutive 
days before being used for a hybridoma fusion, they received daily intraperitoneal 
injections of 20/ag of immunogen in incomplete Freund's. 
The procedure used for the production of hybridomas is described in detail 
elsewhere (22)  and is briefly summarized here. All cultures of hybridomas and 
the NS- 1 myeloma cells used for hybridoma production were grown in Dulbecco's 
Modified Eagle's Medium (4.5 g/l glucose) (Gibeo, Grand Island Biological Co., 
Inc., Grand Island, NY) supplemented with 10% fetal calf  serum (Sterile Systems, 
Logan, UT) and gentamycin (50 ~g/ml). Splenocytes (9  x  107) were obtained 
from  the  immunized mice and  fused with myeloma cells (2  x  107) in  35% 
polyethylene glycol. The cells were suspended in complete medium and plated 
into 96-well cultures plates at a density at 5 x  104 myeloma cells/well. The next 
day, HAT medium was added to select for hybridomas. 
For reasons to be described later, the initial selection for those hybridomas 
producing the desired antibodies was made by immunofluorescence histochem- 
istry. Frozen sections (8/am) of the anterior portion of eyes from 17- to 18-d-old 
chicken embryos were mounted  on  12-spot  glass slides (Shandon  Scientific, 
Shandon Southern Instruments, Inc., Sewickley, PA); a drop of supernatant from 
a hybridoma culture well was added. The slides were incubated overnight at 4°C, 
rinsed in phosphate-buffered saline (PBS), incubated with rhodamine-conjugated 
goat anti-mouse IgG (Cappel Laboratories, Cochranville, PA) for  1 h  at room 
temperature,  rinsed  again  in  PBS  and  mounted  in  glycerol.  Sections  were 
examined by fluorescence optics with a Zeiss photomicroscope equipped with an 
epiilluminator.  Selected hybridomas were cloned by limiting  dilution, and positive 
cultures were expanded. The culture superuatants were harvested, and aliquots 
of cells were frozen and stored in liquid nitrogen. 
Immunofluorescence Observations 
Fluorescence histochemistry was performed  with 8 /am  frozen  sections of 
organs  from  18-d-old  chick  embryos.  Slides were  stained  with  antibody  as 
described above. Some slides were pretreated with testicular hyaluronidase (4,000 
U/ml in PBS;  37°C, Yz h) or pepsin (10 ttg/ml in 0.5 M acetic acid (HOAe); 20 
min,  24°C).  In  all experiments, staining was done  with antibody-containing 
medium from cultures of cloned hybridomas. Observations were usually done 
blind.  Photographs  were taken with Kodak Tri-X  fdm  rated  at  ASA  1,600. 
Control sections were treated and photographed in the same way as the experi- 
mental ones, except that the primary antibody was substituted with one of several 
different high-titre IgG antibodies against determinants not related to type IV 
collagen and not available in the tissues examined. 
Immunological  Characterization 
Antibodies were characterized by both passive hemagglutination  as previously 
described (4, 5) and an enzyme-linked immunosorbent assay (ELISA). ELISAs 
(23, 24) were performed using a Hybridoma Screening Kit (Bethesda Research 
Laboratories, Rockville, MD) and Immulon microtiter plates (Dynatech Corp., 
Alexandria, VA). Wells were coated for at least 3 d with type IV collagen in 20 
mM sodium carbonate buffer, pH 8.6. For most assays, each well was coated 
with 2/ag of collagen, but 0.2 ~g worked equally well. The hyhridoma antibody 
to be examined was added (100/al/well), and the plates were incubated overnight 
at 4°C. Subsequent steps were performed according to the Bethesda Research 
Laboratory  directions.  The  wells were washed and  then  incubated with the 
enzyme-linked  secondary antibody (/3-galactosidase-conj  ugated sheep anti-mouse 
IgG) for 1 h at room temperature. The wells were washed, and thep-nitrophenyl- 
~8-D-galactoside  substrate  was  added  and  allowed to  react  for  1  h  at  room 
temperature. The reaction was stopped by the addition of 0.5 N Na2CO~, and the 
wells were diluted with H20 to a final volume of 0.8 mt and read at 414 nm in a 
Gilford spectrophotometer. 
Inhibition ELISAs were performed  under  nonequilibrium conditions (24). 
Aliquots of the collagens to be tested were dissolved in PBS (pH 7.1),  added to 
the culture medium antibody (diluted 5:1), and reacted overnight at 4°C. 100-bd 
portions of the mixture were added to the collagen-coated wells and incubated 
for 1 h at room temperature to allow free antibody to bind. Succeeding steps in 
the assay were performed as described above. 
Thermal Denaturation 
Before some ELISA experiments, the inhibitory collagens, in either 0.I  M 
HOAc  (pH  2.5)  or  PBS  (pH  7.1),  were  thermally denatured  at  the  desired 
temperature for 0.5 h and then were rapidly cooled to 0°C to prevent renaturation 
(see Discussion). These samples were then used in inhibition ELISAs as described 
above.  Those  denatured  in  PBS  were  reacted  directly with antibody;  those 
denatured in acid were first dialyzed against PBS. RESULTS 
Antibody  Selection  and Characterization 
The  method  of initial  screening  by  immunofluorescence 
histochemistry  with  cryostat  sections  of anterior  eye  tissues 
proved efficient and offers two advantages over other methods 
(25).  It  excludes  any  antibodies  directed  against  antigenic 
determinants  that  are  masked  or  otherwise  inaccessible  in 
tissues in situ, thus ensuring that the antibodies obtained will 
be  useful  for  experiments  involving  immunohistochemical 
analyses  of intact  tissues.  Furthermore,  it  allows  the  initial 
detection  of antibodies  against  each  of the  components and 
molecular domains of a complex antigen or an antigenic mix- 
ture, regardless of their relative quantities. 
Of 359 hybridoma wells tested, 60% showed positive immu- 
nofluorescent staining of one or more of the basement mem- 
branes within the anterior eye (see,  for example, Fig. 4A-C). 
No antibody stained a structure other than a basement mem- 
brane,  indicating  that  the  original  immunogen  preparation 
consisted  largely of type IV collagen  components;  antigenic 
contaminants, if any, could only have been derived from other 
basement  membrane  components.  About fifty positive  wells 
were selected. The cells in some wells were immediately cloned 
by limiting dilution;  in others,  the uncloned cell populations 
were expanded and frozen. Antibody-containing culture super- 
natants from all cloned and uncloned cultures were collected 
and stored at 4°C for further use. All experiments were per- 
formed using spent culture media as the sources of antibodies. 
The culture superuatants were examined for their reactivity 
in  passive :hemagglutination  using  type  IV  collagen-coated 
erythrocytes  and  by  ELISA  using  type  IV  collagen-coated 
microtiter wells.  Only two antibodies gave a positive response 
in the passive hemagglutination assay. One, designated IV-IA8, 
was  strong,  and  the  other  was  weak.  In  the  more  sensitive 
ELISA, all but one of eight antibodies tested gave a  positive 
response  in  wells  coated  with  20  ng  of collagen  (data  not 
shown). The results of the ELISA indicated that most of the 
antibodies were probably directed against domains present in 
type IV collagen.  The  results  of the  hemagglutination  assay 
suggested that the  two positive antibodies  were  produced  in 
response  to quantitatively major components of the  type IV 
collagen preparation.  IV-IA8 has been characterized, and the 
tissue distribution of its antigenic determinant has been docu- 
mented in 18-d-old embryos (see below). 
The immunoglobulin subclass to which IV-IA8 belongs was 
determined  by double  immunodiffusion against  anti-mouse- 
immunoglobulin heavy-chain-specific antibodies. It is an IgG 1. 
The  determination  of  antibody  specificity  by  inhibition 
ELISA indicated that IV-IA8 did not react with highly purified 
native collagen types I, II, III, or V but could be completely 
inhibited  by preincubation  with type IV (Fig.  1). The prepa- 
ration of type III used to generate the data in Fig.  1 had been 
chromatographically purified by DEAE-cellulose chromatog- 
raphy  run  under  nondenaturing  conditions;  the  type V  had 
been purified by precipitation  in 2 M  urea,  0.05  M  Tris HC1 
pH 8.6 (26). They were free of  any type IV collagen components 
as  determined  by  SDS  PAGE.  In less  pure  preparations  of 
types III and V that had been separated from type IV only by 
conventional fractional salt precipitation, the inhibition ELISA 
detected  1-3% cross-reactive material (data not shown). 
The type IV collagen preparations that had been used as the 
immunogen, and  for coating the  wells  for the  ELISA, were 
analyzed by SDS PAGE. They consisted largely of the (F 1)2F2 
component, with smaller amounts of the 7S and F3 domains. 
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FIGURE  1  Inhibition ELISA using antibody IV-IA8, and various con- 
centrations of native collagens (abcissa) as inhibitors. The ordinate 
reports  the  percentage of  the  maximum  absorbance  measured  at 
414 nm.  The upper solid  line shows  the absence of  inhibition  by 
collagen  types  I  (open  triangles),  II  (filled  triangles),  III  (open 
circles),  and V  (filled circles), and by the F3 (asterisks) and 7S (X's) 
domains of type IV collagen. Unfractionated type IV (filled squares; 
lower solid  line)  and  the  isolated  (F1)2F2  domain  (open  squares; 
dashed line) gave nearly identical patterns of strong inhibition. 
FIGURE  2  Elution profile of pepsin-extracted type IV collagen chro- 
matographed under nondenaturing conditions (1 M  CaCI2, 4°C) on 
a  column  of  agarose A-15M;  the  material  in  the  fractions  of  the 
major peak (shown by bar) were pooled and analyzed by SDS PAGE 
on a 5-10% gradient gel  (insert).  It is exclusively (F1)2F2. a, fl, and 
y show the elution patterns of monomeric ~x-chains, fl-chain dimers, 
and y-chain trimers. The elution  position of the denatured  F1  and 
F2 chains is also shown. 
Since  IV-IA8 seemed to be  directed  against  a  quantitatively 
major component, we thought that its antigenic determinant 
might be within (FI)2F2.  To test this,  (F1)2F2 was separated 
from the other type IV collagen domains by gel filtration on 
an Agarose A-15M column run under nondenatufing condi- 
tions.  As can be seen in Fig. 2, native (F1)2F2 elutes slightly 
after the void volume and thus can be obtained free from any 
other  detectable  component,  as  determined  by  SDS  PAGE. 
When  this  highly  purified  (F1)2F2  fraction  was  tested  by 
inhibition ELISA (Fig.  1, dashed line), it inhibited at least as 
well as the unfractionated type IV collagen preparation.  Puri- 
fied 7S and F3 domains gave no inhibition (Fig.  1).  Unfrac- 
tionated type IV collagen purified from kidney showed inhi- 
bition equal to that from gizzard (data not shown). 
The melting temperature  of the triple  helix of (F1)2F2 has 
recently been found to be 33°-34°C in 0.1 M HOAc (pH 2.5), 
as measured by optical rotation (17).  Since most anti-collagen 
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FIGUP.I~ 3  Thermal  dena- 
turation  of  the  antigenic 
determinant  of  antibody 
IV-IA8  determined  by 
inhibition  ELtSA.  Wells 
coated with  100/~1 type IV 
collagen  (20  p.g/ml.).  Ab- 
cissa  =  temperature  to 
which the inhibitor type IV 
collagen  had  been  raised 
for  30  min,  The  ordinate 
reports  the  percentage  of 
the  maximum  absorbance 
measured  at  414  nm.  The 
dashed  line  shows  inhibi- 
tion  by  samples  that  had 
been  heated  in  0.1  M 
HOAc  and  then  dialyzed  to  neutrality at 4°C  (open  circles);  the 
solid line by samples that  had been heated in PiBS in the presence 
(closed triangles) or absence  (closed circles) of 5 mM DTT. 
antibodies  produced  in  mice  are  conformational-dependent 
and  do  not  bind  to  denatured  collagen  (22,  27),  we  asked 
whether the antigenic site within (FI)2F2 was also conforma- 
tional-dependent,  and,  ff so,  how this  relates  to  the  melting 
temperature of (F 1)2F2. Samples of type IV collagen dissolved 
in 0.1  M  HOAc (pH 2.5)  were raised to progressively higher 
temperatures,  rapidly cooled, brought to neutrality with PBS, 
and  antibody  binding  was  tested  by  inhibition  ELISA.  A 
failure  to bind  antibody was observed in  samples  heated  to 
temperatures  >34°C (Fig. 3, dashed line).  When thermal de- 
naturation was performed under more physiological conditions 
of pH and ionic strength (see Discussion), inhibition of ELISA 
with IV-IA8 revealed a shift of the denaturation temperature 
to 38°-39°C (Fig. 3,  solid line).  The 38°-39°C melting tem- 
perature was unaffected by the addition of reducing agents, a 
result also consistent with the determinant being within (F 1)2F2 
which lacks cysteine. 
Immunofluorescence Histochemistry 
The tissue distribution  of the antigenic determinant  recog- 
nized by IV-IA8 was surveyed in a variety of tissues from 18- 
d-old  chicken  embryos.  Representative  immunofluorescence 
micrographs are shown in Figs. 4 and 5. In sections of anterior 
eye (Fig. 4), antibody IV-IA8 outlined the profiles of the ducts 
and/or  blood  vessels  of the  limbal  region  (Fig.  4B,  arrow- 
heads), and the basement membrane of the overlying conjunc- 
tival epithelium (Fig. 4 B, arrow). Bright fluorescence was also 
associated with the anterior lens capsule (but not the posterior 
lens  capsule)  and  the  basement  membranes  of the  anterior 
epithelium of the iris and the iris muscle cells (Fig. 4A). The 
basement  membranes  of the  ciliary  body were  consistently 
stained (Fig. 4 C). We were surprised to fred greatly diminished 
fluorescence, if any, associated with the basement membrane 
of the  corneal  epithelium  (Fig.  4A,  arrow).  Staining  of the 
corneal  endothelial  basement  membrane  (Descemet's  mem- 
brane;  Fig.  4A,  open  arrow)  with  this  antibody  was  also 
markedly reduced compared to that of most other basement 
membranes  and  to  the  staining  of Descemet's  elicited  by a 
variety of antibodies we have produced against noncollagenous 
basement membrane components (25). Nevertheless, faint flu- 
orescence was generally visible in this structure. 
Staining  of the  basement membranes of other organs was 
extensive.  In  the  kidney  (Fig.  5A),  bright  fluorescence was 
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FIGURES 4  and  5  Photomicrographs  of  frozen  sections  of  tissue 
from  18-d-old  chicken  embryos.  All  sections  were  treated  with 
antibody  IV-IA8,  followed  by  rhodamine-conjugated  goat  anti- 
mouse  IgG  secondary antibody,  and  viewed  by  fluorescence  mi- 
croscopy.  Control  and  experimental sections  were treated  identi- 
cally, except the former received one of several high-tiLer mono- 
clonal antibodies  (all  IgG)  against antigenic determinants not de- 
tectable in the tissue instead of IV-IA8. Fig. 4 (above) shows anterior 
eye including cornea, iris, and lens (A), sclera (B), and ciliary body 
(C). Controls (not shown) were completely negative and compara- 
ble to those shown in Fig. 5. ×  113. 
observed in all tubules,  ducts, and glomeruli. Staining within 
skeletal  muscle  (Fig.  5 B)  included  the  basement  membrane 
surrounding each muscle fiber plus intervening capillaries.  In 
the connective tissue surrounding each bundle of  muscle fibers, 
the  walls  of arteries  and  veins  were  brightly  stained;  light 
staining was also found within bundles of nerve (not shown). 
The staining within the walls of the arteries and veins appeared 
to  be  associated  with  smooth  muscle  cells.  In  larger  blood FIGURE  5  (A)  kidney,  (B)  skeletal muscle, and  (C)  large blood vessel,  cvl overlies the region of the collapsed vascular lumen, 
which  is unstained. (D)  Cardiac ventricle. Control sections at the same magnification and exposure times are included as inserts 
in the upper right-hand corner of each picture, x  113. 
vessels (Fig. 5 C), we observed concentric rings of fluorescence 
that  seemed  to  outline  the  layers of smooth muscle,  but  no 
staining was found in the region of the lumen (cvl, Fig. 5 C). In 
contrast, similar sections stained with antibodies to native lens 
capsule (25)  clearly stain the basement membrane of the vas- 
cular endothelium in a  stellate pattern that seems to parallel 
the  profile  of the  collapsed  arterial  lumen  (in  preparation). 
That  the  basement  membranes  of at  least  some  forms  of 
vascular endothelium are positive, however, is evident by bright 
staining of capillaries. This is clearly visible in the myocardium 
of the  heart  ventricle,  in which the  capillary network is  the 
predominant structure stained (Fig. 5 D). 
In all of these experiments, the controls (inserts in the upper 
corner of each figure) were completely negative.  Attempts to 
alter the staining patterns by pretreating the slides to remove 
potential masking substances, such as testicular hyaluronidase- 
sensitive proteoglycans or pepsin-sensitive proteins,  were un- 
successful. 
DISCUSSION 
By immunohistochemical staining, we have identified hybrid- 
omas  producing  antibodies  against  components  of a  highly 
purified  type IV collagen preparation.  A  number of criteria 
indicate that one of these, antibody IV-IA8, is directed against 
the (F l)zF2 component. Preliminary characterization of  several 
other antibodies  by similar procedures suggests that the anti- 
genic determinant  for some  of them  may be  within  the  F3 
domain,  and  for others  within  7S.  If so,  these  will  provide 
comparisons  for  antibody  IV-IA8  and  should  allow  us  to 
evaluate:  (a)  the  current  model of type IV collagen  and  its 
assembly within basement membranes, (b) the variety of anti- 
genic determinants that exists within type IV collagen, and (c) 
the  interaction  of different  molecular  domains  of type  IV 
collagen with other basement membrane components. 
On the basis of the inhibition ELISA analysis, the antigenic 
determinant  recognized  by  IV-IA8  appears  to  be  located 
within, or closely associated with, the (FI)2F2 domain. Addi- 
tional evidence comes from inhibition  ELISA with  collagen 
thermally denatured in 0. l M HOAc, which demonstrated that 
the loss of antibody binding occurs at a temperature similar to 
that at which (F 1)2F2 loses its helical structure, as determined 
by optical rotation (17). While further implicating the (F 1)2F2 
region as the source of the conformational-dependent IV-IA8 
binding site,  this information on thermal stability also raised a 
question.  How  could  a  conformational-dependent  antibody 
against an immunogen that denatures at 33°-34°C be gener- 
ated  in  a  mouse  whose  body  temperature  is  considerably 
higher? One possible answer, that the thermal stability of the 
(F1)2F2 helix is greater in more physiological conditions, was 
indicated by inhibition ELISA with type IV collagen denatured 
in neutral phosphate buffer. This revealed a  Shift in the tem- 
perature  at  which  antibody  binding  was  lost  to  38°-39°C.1 
Although some renaturation may have occurred after cooling, Mayne 
and  Bruckner  (17) have  observed  that  the  helicity  of (FIhF2  as 
measured by optical rotation in 0.1 M HOAc does not readily return 
under these conditions. Furthermore,  the failure to detect binding to 
FITCH  ET AL  Anti-Type IV Collagen Monoclonal Antibody  645 Another possibility  is  that  some of the  type  IV may be  in 
aggregate form in neutral conditions. If  so, or ff such aggregates 
rapidly form upon injection, the melting temperature is likely 
to be substantially elevated, as is the case for type I collagen 
(28). 
The precise biochemical nature of the determinant remains 
to be defined. The overall amino acid composition of (F 1)2F2 
shows it to be largely collagenous; analysis by optical rotatory 
dispersion  and  its  appearance  in  rotary  shadowed  electron 
microscopic preparations (17) are consistent with a collagenlike 
triple helical structure. The amino acid sequence has not been 
determined,  but partial  sequence analysis of homologous re- 
gions  of type  IV collagen  from other  species  indicates  that 
helical  domains  may be  interrupted  by noncollagenous  se- 
quences (15,  16). To establish the type of domain to which IV- 
IA8  binds  will  require  isolation  and  characterization  of a 
fragment of (F1)2F2 containing the binding site.  Preliminary 
experiments suggest that it may be possible to generate such a 
fragment by limited digestion with bacterial collagenase. 
The  immunofluorescence  histochemical  experiments  re- 
vealed that  most basement  membranes  were stained  by IV- 
IA8, but those of the corneal epithelium and the endothelium 
of large blood vessels reacted very slightly, if at all, and that of 
the corneal endotbelium showed a weak but positive reaction. 
This difference could be due to: (a) masking of the antigenic 
determinant in certain basement membranes; (b) the existence 
of a heterogeneous family of immunologlcally distinct type IV 
collagens that have tissue-specific distributions; or (c) a greatly 
reduced  content,  or possibly an  absence,  in  some basement 
membranes of type IV collagen. 
We have attempted to remove potential masking substances 
from the corneal basement membranes by pretreating sections 
with testicular hyaluronidase and pepsin. Neither enzyme pro- 
duced observable changes, suggesting the absence of type IV 
collagen  in  some  tissues.  This  is  supported  by preliminary 
immunofluorescence  histochemical  experiments  with  other 
monoclonal antibodies to the F3 and  7S regions of type IV, 
which behave like IV-IA8 (unpublished observations). Never- 
theless,  this negative result cannot eliminate the possibility that 
type IV collagen is present but strongly and completely masked 
in these tissues but might be exposed by other procedures. We 
have found type V collagen to be masked in a variety of tissues 
stained with monoclonal antibodies (manuscript submitted for 
publication),  but the procedures for unmasking this collagen 
do not appear to affect the staining pattern of IV-IA8 or other 
monoclonal antibodies to type IV collagen. 
The  possibility  that  tissue-specific type  IV collagens exist 
cannot be eliminated and indeed remains an intriguing ques- 
tion for future investigation. 
Finally, the possibility that certain basement membranes, at 
least in some species,  contain little or no type IV collagen must 
be considered. In the human cornea both epithelial and endo- 
thelial basement membranes have been reported to stain with 
a conventional, affinity-purified antibody against type IV col- 
lagen from the EHS-mouse tumor (29; Fujikawa, Foster, and 
Colvin, personal communication; submitted  for publication). 
On the  other hand,  Fujikawa,  Foster,  and  Colvin (personal 
communication;  submitted  for publication),  using  the  same 
type IV collagen denatured  under  both acid and neutral  conditions 
indicates that the extent of  specific reformation of  the binding site was 
negligible. This is probably due  in part to the absence of disulfide 
bonding in (F1)2F2. 
646  THE  JOURNAL OF  CELL BIOLOGY.  VOLUME 95,  1982 
anti-type IV collagen antibodies, have been unable to stain the 
corneal epithelial  basement  membrane  in  rabbits  or guinea 
pigs, although the basement membranes of other tissues from 
these animals react strongly. These differences could therefore 
be  species-related.  In  addition,  there  may  exist  age-related 
differences, since we have observed temporal changes in other 
basement membrane antigens during embryonic development 
(25). Future studies with monoclonal antibodies against differ- 
ent  domains  of the  type  IV  molecule  and  other  basement 
membrane components should make it possible to distinguish 
between  these  alternatives.  In  the  least,  the  differences  in 
staining with the anti-type IV collagen antibody reported here 
may reflect a significant heterogeneity in the quantity or assem- 
bly of this molecule within different basement membranes. 
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